Pseudomonas fluorescens can induce and divert the human β-defensin-2 secretion in intestinal epithelial cells to enhance its virulence

Archives of Microbiology

Volumn 195, Issue 3, 2013, Pages 189-195

  Madi, Amar ^a   Alnabhani, Ziad ^b   Leneveu, Charlène ^a   Mijouin, Lily ^a   Feuilloley, Marc ^a   Connil, Nathalie ^a  

^a UNIVERSITÉ DE ROUEN   (France)

^b INSERM   (France)

Author keywords

Caco 2 TC7; hBD 2; MAPK; NF B; P. fluorescens; Virulence

Indexed keywords

BETA DEFENSIN 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; ANTIINFECTIVE AGENT; BETA DEFENSIN; DEFB4A PROTEIN, HUMAN;

ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; INTESTINE EPITHELIUM CELL; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS FLUORESCENS; PSEUDOMONAS INFECTION; SIGNAL TRANSDUCTION; CELL STRAIN CACO 2; DRUG EFFECT; ENTERITIS; EPITHELIUM CELL; HUMAN; INTESTINE; INTESTINE CELL; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY; VIRULENCE;

BACTERIA (MICROORGANISMS); PSEUDOMONAS FLUORESCENS;

ANTI-INFECTIVE AGENTS; BETA-DEFENSINS; CACO-2 CELLS; ENTEROCYTES; EPITHELIAL CELLS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; MAP KINASE SIGNALING SYSTEM; NF-KAPPA B; PSEUDOMONAS FLUORESCENS; VIRULENCE;

MLCS; MLOWN;

EID: 84875825207     PISSN: 03028933     EISSN: 1432072X     Source Type: Journal    
DOI: 10.1007/s00203-012-0865-3     Document Type: Article

References (29)

1. Bardoel BW, van der Ent S, Pel MJ, Tommassen J, Pieterse CM, van Kessel KP, van Strijp JA (2011) Pseudomonas evades immune recognition of flagellin in both mammals and plants. PLoS Pathog 7:e1002206
2. Blier AS, Veron W, Bazire A, Gerault E, Taupin L, Vieillard J, Rehel K, Dufour A, Le Derf F, Orange N, Hulen C, Feuilloley MG, Lesouhaitier O (2011) C-type natriuretic peptide modulates quorum sensing molecule and toxin production in Pseudomonas aeruginosa. Microbiology 157:1929-1944
3. Burini JF, Gugi B, Merieau A, Guespin-Michel JF (1994) Lipase and acidic phosphatase from the psychrotrophic bacterium Pseudomonas fluorescens: two enzymes whose synthesis is regulated by the growth temperature. FEMS Microbiol Lett 122:13-18
4. Chamaillard M, Dessein R (2011) Defensins couple dysbiosis to primary immunodeficiency in Crohn's disease. World J Gastroenterol 17:567-571
5. Chapalain A, Rossignol G, Lesouhaitier O, Merieau A, Gruffaz C, Guerillon J, Meyer JM, Orange N, Feuilloley MG (2008) Comparative study of 7 fluorescent pseudomonad clinical isolates. Can J Microbiol 54:19-27
6. Dalwadi H, Wei B, Kronenberg M, Sutton CL, Braun J (2001) The Crohn's disease-associated bacterial protein I2 is a novel enteric t cell superantigen. Immunity 15:149-158
7. Donnarumma G, Buommino E, Fusco A, Paoletti I, Auricchio L, Tufano MA (2010) Effect of temperature on the shift of Pseudomonas fluorescens from an environmental microorganism to a potential human pathogen. Int J Immunopathol Pharmacol 23:227-234
8. Dössel J, Meyer-Hoffert U, Schröder JM, Gerstel U (2012) Pseudomonas aeruginosa-derived rhamnolipids subvert the host innate immune response through manipulation of the human beta-defensin-2 expression. Cell Microbiol 14:1364-1375
9. Ganz T (2005) Defensins and other antimicrobial peptides: a historical perspective and an update. Comb Chem High Throughput Screen 8:209-217
10. Hancock RE, Scott MG (2000) The role of antimicrobial peptides in animal defenses. Proc Natl Acad Sci USA 97:8856-8861
11. Huang LC, Redfern RL, Narayanan S, Reins RY, McDermott AM (2007) In vitro activity of human beta-defensin 2 against Pseudomonas aeruginosa in the presence of tear fluid. Antimicrob Agents Chemother 51:3853-3860
12. Jackson MK, Phillips SN (1996) Necrotizing hepatitis in pet birds associated with Pseudomonas fluorescens. Avian Dis 40:473-476
13. Jung MY, Kim HS, Hong HJ, Youn BS, Kim TS (2012) Adiponectin induces dendritic cell activation via PLCgamma/JNK/NF-kappaB pathways, leading to Th1 and Th17 polarization. J Immunol 188:2592-2601
14. Klockgether J, Munder A, Neugebauer J, Davenport CF, Stanke F, Larbig KD, Heeb S, Schöck U, Pohl TM, Wiehlmann L, Tümmler B (2010) Genome diversity of Pseudomonas aeruginosa PAO1 laboratory strains. J Bacteriol 192(4):1113-1121
15. Madi A, Lakhdari O, Blottière HM, Guyard-Nicodème M, Le Roux K, Groboillot A, Svinareff P, Doré J, Orange N, Feuilloley MG, Connil N (2010a) The clinical Pseudomonas fluorescens MFN1032 strain exerts a cytotoxic effect on epithelial intestinal cells and induces Interleukin-8 via the AP-1 signaling pathway. BMC Microbiol 10:215
16. Madi A, Svinareff P, Orange N, Feuilloley MG, Connil N (2010b) Pseudomonas fluorescens alters epithelial permeability and translocates across Caco-2/TC7 intestinal cells. Gut Pathog 2:16
17. Nuding S, Zabel LT, Enders C, Porter E, Fellermann K, Wehkamp J, Mueller HA, Stange EF (2009) Antibacterial activity of human defensins on anaerobic intestinal bacterial species: a major role of HBD-3. Microbes Infect 11:384-393
18. Okuda J, Hayashi N, Okamoto M, Sawada S, Minagawa S, Yano Y, Gotoh N (2010) Translocation of Pseudomonas aeruginosa from the intestinal tract is mediated by the binding of ExoS to an Na, K-ATPase regulator, FXYD3. Infect Immun 78:4511-4522
19. Picot L, Mezghani-Abdelmoula S, Chevalier S, Merieau A, Lesouhaitier O, Guerillon J, Cazin L, Orange N, Feuilloley MG (2004) Regulation of the cytotoxic effects of Pseudomonas fluorescens by growth temperature. Res Microbiol 155:39-46
20. Ramasundara M, Leach ST, Lemberg DA, Day AS (2009) Defensins and inflammation: the role of defensins in inflammatory bowel disease. J Gastroenterol Hepatol 24:202-208
21. Schneider JJ, Unholzer A, Schaller M, Schafer-Korting M, Korting HC (2005) Human defensins. J Mol Med (Berl) 83:587-595
22. Selsted ME, Ouellette AJ (2005) Mammalian defensins in the antimicrobial immune response. Nat Immunol 6:551-557
23. Sperandio D, Rossignol G, Guerillon J, Connil N, Orange N, Feuilloley MG, Merieau A (2010) Cell-associated hemolysis activity in the clinical strain of Pseudomonas fluorescens MFN1032. BMC Microbiol 10:124
24. Veldhuizen EJ, Rijnders M, Claassen EA, van Dijk A, Haagsman HP (2008) Porcine beta-defensin 2 displays broad antimicrobial activity against pathogenic intestinal bacteria. Mol Immunol 45:386-394
25. Veron W, Orange N, Feuilloley MG, Lesouhaitier O (2008) Natriuretic peptides modify Pseudomonas fluorescens cytotoxicity by regulating cyclic nucleotides and modifying LPS structure. BMC Microbiol 8:114
26. Wehkamp J, Harder J, Wehkamp K, Wehkamp-von Meissner B, Schlee M, Enders C, Sonnenborn U, Nuding S, Bengmark S, Fellermann K, Schröder JM, Stange EF (2004) NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect Immun 72:5750-5758
27. Wehkamp J, Fellermann K, Stange EF (2005) Human defensins in Crohn's disease. Chem Immunol Allergy 86:42-54
28. Wehkamp K, Schwichtenberg L, Schroder JM, Harder J (2006) Pseudomonas aeruginosa- and IL-1beta-mediated induction of human beta-defensin-2 in keratinocytes is controlled by NF-kappaB and AP-1. J Invest Dermatol 126:121-127
29. Yoon YM, Lee JY, Yoo D, Sim YS, Kim YJ, Oh YK, Kang JS, Kim S, Kim JS, Kim JM (2010) Bacteroides fragilis enterotoxin induces human beta-defensin-2 expression in intestinal epithelial cells via a mitogen-activated protein kinase/I kappaB kinase/NF-kappaB-dependent pathway. Infect Immun 78:2024-2033